killer cell immunoglobulin-like receptorsKIR geneshematopoietic stem cell transplantationdonorиммуноглобулиноподобные рецепторы киллерных клетокKIR-генытрансплантация гемопоэтических стволовых клетокдонор1.McQueen K.L., Parham P. Variable receptors controlling activation and inhibition of NK cells. Current opinion in Immunology 2002; 14: 615-21.2.Mandelboim O., Reyburn H.T., Vales-Gomez M., et al. Protection from lysis by natural killer cell of group 1 and 2 specificity is mediated by residue 80 in human Histocompatibility Leukocyte Antigen C alleles and also occurs with empty Major Histocompatibility Complex molecules. The Journal of Experimental Medicine 1996; 184: 913-22.3.Thananchai H., Gillespie G., Martin M.P., et al. Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. The Journal of Immunol 2007; 178: 33-7.4.Ljunggren H.G., Karre K. In search of the «missing self»: MHC molecules and NK cell recognition. Immunology today 1990; 11: 237-44.5.Rugerri L., Capanni M., Casucci M., Volpi I., et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94: 333-9.6.Uhrberg M., Valiante N.M., Shum B.P., et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753-63.7.Witt C.S., Dewing C.B., Sayer D.C., et al. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation 1999; 68: 1784-89.8.Mehra N.K., Kaur G., McCluskey J., et al. The HLA complex in Biology and Medicine: A Resource Book 2010; 31: 526-27.9.Savani B.N., Mielke S., Adams S., Uribe M., et al. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia. Leukemia 2007; 21: 2145-52.10.Maschan M., Shelikhova L., Ilushina M., et al. TCR-alpha/beta and CD19 depletion and threosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia. Bone Marrow Transplant 2016; 51 (5): 668-74.11.Balashov D., Shcherbina A., Maschan M., et. al. Single-center experience of unrelated and haploidentical stem cell transplantation with TCR and CD19 depletion in children with primary immunodeficiency syndromes. Biol Blood Marrow Transplant 2015; 21 (11): 1955-62.12.Laberko A., Bogoyavlenskaya A., Shelikhova L., et. al. Risk Factors and the Clinical impact of Cytomegalovirus and Epstein-Barr Virus infections in Pediatric Recipients of TCR and CD19-Depleted Grafts. Biol Blood Marrow Transplant 2017; 23 (3): 483-90.13.Balashov D., Laberko A., Shcherbina A., et. al. A Conditioning Regimen with Plerixafor is Safe and Improves the Outcome of TCR and CD19+-Cell-Depleted Stem Cell Transplantation in Patients with Wiskott-Aldrich Syndrome. Biol Blood Marrow Transplant 2018;(18): 30119-8.14.http://hla.alleles.org/dictionary/index.html15.Biassoni R., Vanni I., Ugolotti E. Killerimmunoglobulin-like receptors and their ligands. Histocompatibility book 2012; 6: 97-9.Biassoni R., Vanni I., Ugolotti E. Killerimmunoglobulin-like receptors and their ligands. Histocompatibility book 2012; 6: 97-9.16.http://www.ebi.ac.uk/ipd/kir17.Cooley S., Weisdorf D.J., Guethlein L.A., et al. Donor selection for natural killer receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood 2010; 116: 2411-19.18.Rajalingham R. Overview of the killer cell immunoglobulin-like receptor sys-tem. Methods in Molecular Biology Book 2012; 882: 391-414.19.Oevermann L., Michaelis S.U., Mezger M., Lang P., et al. KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL. Blood 2014; 124: 2744-7.20.Torelli G.F., Peragine N., Raponi S., et al. Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells. Haematologica 2014; 99: 1248-54.21.Yabe T., Matsuo K., Hirayasu K., et al. Donor killer immunoglobulin-like receptor genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T-cell-replete unrelated bone marrow transplantation. Biol Blood Marrow Transplant 2008; 14: 75-87.22.Cooley S., McCullar V., Wangen R., et al. KIR reconstitution is altered by T-cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood 2005; 106: 4370-76.